FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称SATRALIZUMAB
异名/同义词ENSPRYNG
HUMANISED ANTI-IL-6 RECEPTOR MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G2, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL SA237 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SA237 LIGHT CHAIN, DIMER
SA237
SA-237
SAPELIZUMAB
SATRALIZUMAB
SATRALIZUMAB [INN]
SATRALIZUMAB [JAN]
SATRALIZUMAB [MI]
SATRALIZUMAB [USAN]
SATRALIZUMAB [WHO-DD]
SATRALIZUMAB MWGE [WHO-DD]
SATRALIZUMAB-MWGE
CAS登记号1535963-91-7
物质唯一标识(Unique Ingredient Identifier)YB18NF020M
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 日本药品名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System